Ontology highlight
ABSTRACT:
SUBMITTER: Liu J
PROVIDER: S-EPMC7922397 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
Liu Jinsha J Pandya Priyanka P Afshar Sepideh S
International journal of molecular sciences 20210218 4
Around 77 new oncology drugs were approved by the FDA in the past five years; however, most cancers remain untreated. Small molecules and antibodies are dominant therapeutic modalities in oncology. Antibody-drug conjugates, bispecific antibodies, peptides, cell, and gene-therapies are emerging to address the unmet patient need. Advancement in the discovery and development platforms, identification of novel targets, and emergence of new technologies have greatly expanded the treatment options for ...[more]